Skip to main content

Effects of HRT on Metabolic Risk Factors for Cardiovascular Disease

  • Chapter
Women’s Health in Menopause

Part of the book series: Medical Science Symposia Series ((MSSS,volume 7))

  • 110 Accesses

Abstract

The immediate effects of estrogen deficiency are well known and include vasomotor, psychological, and genitourinary symptoms. However, the major importance of the long-term effects of estrogen deficiency, particularly on the skeleton and the cardiovascular system, is now being recognized. Thus, when using hormone replacement therapy (HRT), it is important to consider its effects on osteoporosis and cardiovascular disease as well as on symptom relief. There are several mechanisms whereby HRT can affect the cardiovascular system; these include both metabolic and direct arterial effects. An increased understanding of these mechanisms should allow us to develop optimal HRT regimens for the prevention and treatment of cardiovascular disease in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stevenson JC. Osteoporosis and cardiovascular disease in women: converging paths? Lancet 1990;336:1121–22.

    Article  Google Scholar 

  2. LaCroix AZ, Haynes SG, Savage DD, Havlink RJ. Rose questionnaire angina among United States black, white and Mexican-American women and men. Am J Epidemiol 1989;129:669–86.

    PubMed  CAS  Google Scholar 

  3. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157–61.

    PubMed  CAS  Google Scholar 

  4. Knopp RH. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol 1988;72:23S–30S.

    PubMed  CAS  Google Scholar 

  5. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83–90.

    Article  PubMed  CAS  Google Scholar 

  6. Proudler AJ, Felton C, Stevenson JC. Aging and the plasma insulin, glucose and C-peptide response to intravenous glucose in postmenopausal women. Clin Sci 1992;83:489–94.

    PubMed  CAS  Google Scholar 

  7. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 1993;23:466–73.

    Article  PubMed  CAS  Google Scholar 

  8. Ley CI, Lees B, Stevenson JC. Sex-and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992;55:950–54.

    PubMed  CAS  Google Scholar 

  9. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet 1991;338:839–42.

    Article  PubMed  CAS  Google Scholar 

  10. Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Folow-up Study. Circulation 1987;75:1102–09.

    Article  PubMed  CAS  Google Scholar 

  11. Falkeborn M, Persson I, Adami H-O et al. The risk of acute myocardial infarction after estrogen and estrogen/progestagen replacement. Br J Obstet Gynaecol 1992;99:821–28.

    Article  PubMed  CAS  Google Scholar 

  12. Adams MR, Kaplan JR, Manuck SB et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis 1990;10:1051–57.

    Article  PubMed  CAS  Google Scholar 

  13. Sullivan JM, Zwang RV, Hughes JP et al. Estrogen replacement and coronary artery disease. Arch Int Med 1990;150:2557–62.

    Article  CAS  Google Scholar 

  14. Crook D, Stevenson JC, Progestogens, lipid metabolism and hormone replacement therapy. Br J Obstet Gynaecol 1991;98:749–50.

    Article  PubMed  CAS  Google Scholar 

  15. Bengtsson C, Björkelund C, Lapidus L, Lissner L. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. Br Med J 1993;307:1385–88.

    CAS  Google Scholar 

  16. Crook D, Cust MP, Gangar KF et al. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects of serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950–55.

    PubMed  CAS  Google Scholar 

  17. Utermann G. The mysteries of lipoprotein (a). Science 1989;264:904–10.

    Article  Google Scholar 

  18. Crook D, Sidhu M, Seed M, O’Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992;92:41–47.

    Article  PubMed  CAS  Google Scholar 

  19. Rymer J, Crook D, Sidhu M, Chapman M, Stevenson JC. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women. Acta Endocrinol 1993;128:259–62.

    PubMed  CAS  Google Scholar 

  20. Farrish E, Rolton HA, Barnes JF, Hart DM. Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. Br Med J 1991;303:694.

    Article  Google Scholar 

  21. Krauss RM. The tangled web of coronary risk factors. Am J Med 1991;90:36S–41S.

    Article  PubMed  CAS  Google Scholar 

  22. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785–92.

    Article  Google Scholar 

  23. Sack MN, Rader DJ, Cannon RO. Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269–70.

    Article  PubMed  CAS  Google Scholar 

  24. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. Am J Clin Nutr 1956;4:20–34.

    PubMed  CAS  Google Scholar 

  25. Stevenson JC, Lees B, Bruce R, Ley C, Crook D. Influence of body composition on lipid metabolism in postmenopausal women. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990:1837–38.

    Google Scholar 

  26. Ley CJ, Swan JW, Godsland IF, Walton C, Crook D, Stevenson JC. Insulin resistance, lipoproteins, body fat and hemostasis in non-obese males with angina and normal or abnormal coronary angiograms. J Am Coll Cardiol 1994;23:377–83.

    Article  PubMed  CAS  Google Scholar 

  27. Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994;105:209–16.

    Article  PubMed  CAS  Google Scholar 

  28. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323–26.

    Article  PubMed  CAS  Google Scholar 

  29. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  30. Godsland IF, Gangar KF, Walton C et al. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993;42:846–53.

    Article  PubMed  CAS  Google Scholar 

  31. Fox J, George AJ, Newton JR et al. Effect of transdermal estradiol on the haemostatic balance of menopausal women. Maturitas 1993;18:55–64.

    Article  PubMed  CAS  Google Scholar 

  32. Winkler UH, Koslowski S, Oberhoff C, Schindler EM, Schindler AE. Changes of the dynamic equilibrium of hemostasis associated with the use of low dose oral contraceptives: a controlled study of cyproteroneacetate containing oral contraceptives combined with either 35 or 50 µg ethinylestradiol. Adv Contracept 1991;7:273–84.

    Google Scholar 

  33. Winkler UH. Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis 1992;6 suppl. 3:5–10.

    Google Scholar 

  34. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal estrogen treatment and stroke: a prospective study. Br Med J 1988;297:519–22.

    Article  CAS  Google Scholar 

  35. Ross RK, Pike MC, Mack TM, Henderson BE. Estrogen replacement therapy and cardiovascular disease. In: Drife JO, Studd JWW, editors. HRT and Osteoporosis. London: Springer-Verlag, 1990:209–22.

    Chapter  Google Scholar 

  36. Lowe GDO, Greer IA, Cooke TG et al. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992;305:567–74.

    Article  Google Scholar 

  37. Stevenson JC, Macdonald DWR, Warren RC, Booker MW, Whitehead MI. Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J 1986;293:1329–30.

    Article  CAS  Google Scholar 

  38. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circ Res 1990;81:1680–87.

    CAS  Google Scholar 

  39. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17ß-estradiol in vitro. Br J Pharmacol 1991;104:1033–37.

    Article  PubMed  CAS  Google Scholar 

  40. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen - a calcium antagonist effect? Lancet 1993;341:1264–65.

    Article  PubMed  CAS  Google Scholar 

  41. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17ßestradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271–75.

    PubMed  CAS  Google Scholar 

  42. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17ß-estradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739–45.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Stevenson, J.C. (1994). Effects of HRT on Metabolic Risk Factors for Cardiovascular Disease. In: Crosignani, P.G., Paoletti, R., Sarrel, P.M., Wenger, N.K., Meschia, M., Soma, M. (eds) Women’s Health in Menopause. Medical Science Symposia Series, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1024-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1024-2_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4446-2

  • Online ISBN: 978-94-011-1024-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics